Christopher Loose

Christopher Loose

Plus aucun poste en cours
45 ans
Health Technology
Consumer Services
Finance

Profil

Christopher R.
Loose
was the founder of Semprus BioSciences Corp., founded in 2007, serving as Chief Technology Officer from 2007 to 2012.
Dr. Loose was the founder of Frequency Therapeutics, Inc., founded in 2014, serving as Chief Scientific Officer in 2023.
Loose is also the founder of Progentos Therapeutics, Inc...
Dr. Loose is Executive Director at the Center For Integration of Medicine & Innovative Technology.
Loose is Executive Director at Yale School of Medicine since 2014.
Loose was Principal at Merck Research Laboratories Massachusetts LLC from 2002 to 2003.
Loose was Chief Scientific Officer at Korro Bio, Inc. Dr. Loose earned a doctorate from Massachusetts Institute of Technology in 2007.
Loose earned an undergraduate degree from Princeton University in 2002.

Postes actifs de Christopher Loose

SociétésPosteDébut
Directeur/Membre du Conseil 01/06/2014
Center For Integration of Medicine & Innovative Technology
Directeur/Membre du Conseil -

Anciens postes connus de Christopher Loose

SociétésPosteFin
KORRO BIO, INC. Directeur Général 07/03/2023
Fondateur 01/06/2012
Corporate Officer/Principal 01/08/2003
Voir l'expérience en détail de Christopher Loose

Formation de Christopher Loose

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

94

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Finance

Consumer Services

Health Technology

Center For Integration of Medicine & Innovative Technology

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. Christopher Loose